RT Journal Article SR Electronic T1 685 A first-in-human Phase 1/2 clinical trial of SIRPαlow activated macrophages (SIRPant-M) for the treatment of R/R-NHL JF Journal for ImmunoTherapy of Cancer JO J Immunother Cancer FD BMJ Publishing Group Ltd SP A778 OP A778 DO 10.1136/jitc-2023-SITC2023.0685 VO 11 IS Suppl 1 A1 Kidder, Koby A1 Barcia, Rita N A1 Fogelson, Stephen A1 Fratazzi, Candida A1 McCurley, Nathanael YR 2023 UL http://jitc.bmj.com/content/11/Suppl_1/A778.abstract AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.